Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City.
Bacteremia
/ diagnosis
Betacoronavirus
/ isolation & purification
Blood Culture
/ statistics & numerical data
COVID-19
Coinfection
/ diagnosis
Coronavirus Infections
/ complications
Hospitals
Humans
New York City
/ epidemiology
Pandemics
Pneumonia, Viral
/ complications
Prevalence
Retrospective Studies
SARS-CoV-2
COVID-19
SARS-CoV-2
bacteremia
blood culture
sepsis
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
23 Jul 2020
23 Jul 2020
Historique:
received:
24
04
2020
accepted:
11
05
2020
pubmed:
15
5
2020
medline:
6
8
2020
entrez:
15
5
2020
Statut:
epublish
Résumé
A surge of patients with coronavirus disease 2019 (COVID-19) presenting to New York City hospitals in March 2020 led to a sharp increase in blood culture utilization, which overwhelmed the capacity of automated blood culture instruments. We sought to evaluate the utilization and diagnostic yield of blood cultures during the COVID-19 pandemic to determine prevalence and common etiologies of bacteremia and to inform a diagnostic approach to relieve blood culture overutilization. We performed a retrospective cohort analysis of 88,201 blood cultures from 28,011 patients at a multicenter network of hospitals within New York City to evaluate order volume, positivity rate, time to positivity, and etiologies of positive cultures in COVID-19. Ordering volume increased by 34.8% in the second half of March 2020 compared to the level in the first half of the month. The rate of bacteremia was significantly lower among COVID-19 patients (3.8%) than among COVID-19-negative patients (8.0%) and those not tested (7.1%) (
Identifiants
pubmed: 32404482
pii: JCM.00875-20
doi: 10.1128/JCM.00875-20
pmc: PMC7383550
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : L30 AI133789
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007531
Pays : United States
Informations de copyright
Copyright © 2020 American Society for Microbiology.
Références
Pediatrics. 2004 Jun;113(6):1728-34
pubmed: 15173498
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290902
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
J Clin Microbiol. 1997 May;35(5):1290-2
pubmed: 9114430
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134
pubmed: 32119647
Ann Acad Med Singapore. 2006 May;35(5):326-31
pubmed: 16829999
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet Glob Health. 2020 Jun;8(6):e754-e755
pubmed: 32278364
J Clin Microbiol. 2001 Jun;39(6):2079-82
pubmed: 11376038
Pediatr Infect Dis J. 1999 Mar;18(3):258-61
pubmed: 10093948
Clin Chim Acta. 2020 Jun;505:190-191
pubmed: 32145275
J Microbiol Immunol Infect. 2014 Dec;47(6):518-25
pubmed: 23932366
J Clin Microbiol. 2005 May;43(5):2506-9
pubmed: 15872297
J Microbiol Immunol Infect. 2018 Dec;51(6):697-704
pubmed: 28716363